News
-
SkyePharma has announced that AstraZeneca will pay $8 million in January 2013 “to settle certain disputes” resulting from AZ’s termination of their licensing deal for the Pulmicort MDI. The deal was terminated after AZ discontinued… Read more . . .
-
Copley Scientific has launched a set of tools for inhaler testing qualification called the Flow-Time Verification kit. The kit allows for automatic measurement of flow duration, eliminating the need for stopwatches or the use of… Read more . . .
-
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion regarding Alexza Pharmaceutical’s marketing application for Adasuve Staccato loxapine for the treatment of agitation in… Read more . . .
-
An effort to return remaining units of Primatene Mist epinephrine inhalers to the market failed in the US House of Representatives on December 12, 2012 by a vote of 229-182. Primatene Mist, a CFC-propelled MDI… Read more . . .
-
RDD Online and Aptar Pharma have announced that registration for RDD Europe 2013 is now open. The meeting will take place at the Intercontinental Hotel in Berlin, Germany, May 21-24, 2013, with more than 450… Read more . . .
-
Theravance has begun a dose ranging Phase 2b study of its TD-4208 inhalation solution in approximately 60 patients with moderate to severe COPD. According to the company, “The goal of Theravance’s LAMA program for respiratory… Read more . . .
-
Aptar Pharma has “significantly increased” the production capacity at its facility in Eigeltingen, Germany for nasal delivery pumps for preservative free formulations, the company says, in order to meet continuously rising demand for preservative free… Read more . . .
-
Aradigm Corporation has agreed to sell 50 million shares of common stock at $0.12 per share to two existing shareholders, generating net proceeds of approximately $5.6 million after fees and expenses. According to Aradigm President… Read more . . .
-
Device company Clement Clarke International has launched the Flo-Tone MDI trainer, a device that connects to the mouthpiece of a metered dose inhaler to assist patients and healthcare providers in learning proper inhalation technique. The… Read more . . .
-
Almirall’s Tudorza Pressair aclidinium bromide dry powder inhaler for the maintenance treatment of COPD is now available in the United States, where it is being marketed by Forest Laboratories. The twice-daily anticholinergic was approved in… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
October 21-October 22: MVIC Symposium, Lund, Sweden
November 10-November 11: Rescon Europe 2026, Porto, Portugal
December 9-December 11: DDL 2026, Edinburgh, Scotland